Clinical trial

A Study of SBRT Combined With Puterizumab in Intrapulmonary Metastasis From NSCLC

NCT06434740

StatusNOT_YET_RECRUITING

Study typeINTERVENTIONAL

Start date2024-06-01

PhasePHASE2

Study timeline

Study start (estimated)2024-06-01Date precision: day

Registry last updated2024-05-30

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Non-Small-Cell Lung Cancerunresolved

Interventions

Stereotactic Body Radiation Therapy，SBRTRADIATION

PuterizumabDRUG

Sponsors & collaborators

Sir Run Run Shaw Hospitallead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06434740 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.